Drugdiscovery >> Clinical Trials >> News
4653
Views
Prophylaxis of organ rejection and prophylaxis of fungal infections in liver transplant patients - new insights - drugdiscovery.com
Prophylaxis of organ rejection and prophylaxis of fungal infections in liver transplant patients - new insights - drugdiscovery.com


The results of several studies provide new insights and considerations for immunosuppressive treatment and treatment of fungal infections in liver transplant patients.
Read More >>


Tags: liver transplantation, organ rejection, fungal infection, immunosuppressive treatment - September 13, 2013
Related Articles
17047
Views
Autologous immune cell therapy tested in liver cancer patients Autologous immune cell therapy tested in liver cancer patients
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of proprietary cell therapies for certain degenerative and malignant diseases, announced positive results from its phase Read More >>

Tags: cancer stem cell, dendritic cell, immunotherapy, liver cancer, phase I trial, liver cancer, hepatocellular carcinoma, HCC, clinical trial, immune cells, therapy, dendritic cells

5487
Views
FDA grants Fast Track designation for Galectin’s liver drug FDA grants Fast Track designation for Galectin’s liver drug
The drug, GR-MD-O2 (galactoarabino-rhamnogalacturonate), is now tested in phase I clinical trial for treatment of patients with fatty liver disease and advanced fibrosis. Preclinical data shown that G Read More >>

Tags: Galectin Therapeutics, fatty liver disease, liver, clinical trials, FDA approval, fast track designation

2813
Views
Clinical Trials: too slow for dying patients? Clinical Trials: too slow for dying patients?
Speed of clinical trials are sometimes too slow for dying patients. What we can do to speed up the process and enable patients to get the medicine on time? Can anything end the lethally slow process? Read More >>

Tags: process, patients, clinical trials

7030
Views
Special Protocol Assessment  for a Phase 3 clinical trial of antibiotic plazomicin Special Protocol Assessment for a Phase 3 clinical trial of antibiotic plazomicin
Plazomicin is a next-generation aminoglycoside antibiotic engineered by Achaogen. It has potent bactericidal activity against important gram-negative pathogens, including carbapenem-resistant Enteroba Read More >>

Tags: plazomicin, antibiotic, aminoglycoside antibiotic, next generation, Achaogen, gram-negative, CRE, clinical trial, multi-drug resistant, MDR, bacterial infections

7064
Views
Promising results in Phase II clinical trials of Tirasemtiv in patients with ALS Promising results in Phase II clinical trials of Tirasemtiv in patients with ALS
Cytokinetics’ drug Tirasemtiv, a fast skeletal muscle troponin activator, shows safe and tolerable in two prior Phase 2 trials in patients with amyotrophic lateral sclerosis (ALS). The compound is Read More >>

Tags: Tirasemtiv, ALS, clinical trial, skeletal muscle troponin activator, amyotrophic lateral sclerosis, Cytokinetics

4818
Views
Tresiba efficient in type 2 diabetes patients - study shows Tresiba efficient in type 2 diabetes patients - study shows
The results of the study demonstrate that Novo Nordisk’s recently launched drug Tresiba (insulin degludec) enables patients with type 2 diabetes to sustain good long-term glycemic control, when used Read More >>

Tags: Tresiba, glycemic control, type 2 diabetes, Novo Nordisk, insulin degludec

6676
Views
 Melflufen enters Phase II study in the treatment of multiple myeloma patients Melflufen enters Phase II study in the treatment of multiple myeloma patients
Melflufen, also known as J1, will be used in combination with dexamethasone for late stage, relapsing or relapsing/refractory patients with multiple myeloma. The aim of this phase study is to determi Read More >>

Tags: melflufen, J1, multiple myeloma, late stage, clinical trial

4499
Views
Promising new therapy for  Duchenne muscular dystrophy patients Promising new therapy for Duchenne muscular dystrophy patients
In the first study from a double-blind controlled randomized trial, Sarepta Therapeutics’ drug eteplirsen, improved walking performance of DMD patients. Although the first results are promising, f Read More >>

Tags: Duchenne muscular dystrophy, clinical trials, DMD,Sarepta Therapeutics, eteplirsen

2815
Views
New hope for patients with progressive thyroid cancer New hope for patients with progressive thyroid cancer
Two recent clinical trials have shown that patients with progressive thyroid cancer can benefit from the treatment with two drugs, a kinase inhibitor - sorafenib and BRAFV600E inhibitor - vemurafenib, Read More >>

Tags: thyroid cancer, progressive, sorafenib, vemurafenib, kinase inhibitor, BRAFV600E, mutation, inhibitor, PTC, treatment

5891
Views
Trajenta successful  in Phase III trial in elderly Type 2 diabetes patients Trajenta successful in Phase III trial in elderly Type 2 diabetes patients
Trajenta (linagliptin), marketed by Eli Lilly and Boehringer Ingelheim, showed safe and effective in Phase III trial, significantly reducing the blood glucose levels in elderly people with Type 2 diab Read More >>

Tags: Trajenta, type 2 diabetes, elderly, blood glucose control

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013